FDA Inspection
Vivex Biologics, Inc.Vivex Biologics, Inc. – FDA Inspection, Dec 14, 2012
Record Details
This FDA Inspection record concerns Vivex Biologics, Inc., with an inspection on December 14, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vivex Biologics, Inc.
- Inspection Date
- December 14, 2012
- Product Type
- Biologics
View Company Profile
ID · a891d4c2-8d07-439d-a20e-340b4f24daa3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 809091
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Vivex Biologics, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 12, 2024 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 4, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 21, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 6, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 18, 2015 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Vivex Biologics, Inc.
- FDA Inspection 1226932 - 2024-01-12
- FDA Inspection 1176417 - 2022-08-04
- FDA Inspection 1067763 - 2018-09-21
- FDA Inspection 1016973 - 2017-07-06
- FDA Inspection 951971 - 2015-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.